AMPK activation: a therapeutic target for type 2 diabetes?
about
Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging MoleculesAdenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapyImmune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesDiscovery of Novel Insulin Sensitizers: Promising Approaches and Targets.Treadmill exercise ameliorates the regulation of energy metabolism in skeletal muscle of NSE/PS2m-transgenic mice with Alzheimer's disease.Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep.Caulerpa lentillifera extract ameliorates insulin resistance and regulates glucose metabolism in C57BL/KsJ-db/db mice via PI3K/AKT signaling pathway in myocytesLong-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study.Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolismInsulin inhibits AMPK activity and phosphorylates AMPK Ser⁴⁸⁵/⁴⁹¹ through Akt in hepatocytes, myotubes and incubated rat skeletal muscle.Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.Diabetes-Related Ankyrin Repeat Protein (DARP/Ankrd23) Modifies Glucose Homeostasis by Modulating AMPK Activity in Skeletal MuscleAMP-Activated Protein Kinase Regulates Oxidative Metabolism in Caenorhabditis elegans through the NHR-49 and MDT-15 Transcriptional RegulatorsInterventions to Slow Aging in Humans: Are We Ready?Newer antidiabetic drugs and calorie restriction mimicry.Substance P enhances the activation of AMPK and cellular lipid accumulation in 3T3‑L1 cells in response to high levels of glucoseObesity decreases B cell responses in young and elderly individualsAnti-diabetic activities of catalpol in db/db mice.Programming Effects of Prenatal Glucocorticoid Exposure with a Postnatal High-Fat Diet in Diabetes Mellitus.Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Simulated Microgravity and Recovery-Induced Remodeling of the Left and Right VentricleEffect of Exendin-4 on Autophagy Clearance in Beta Cell of Rats with Tacrolimus-induced Diabetes Mellitus.Beneficial Effects of Berberine on Oxidized LDL-Induced Cytotoxicity to Human Retinal Müller Cells.Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D).Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation.Metformin, an old drug, brings a new era to cancer therapyCreatine Prevents the Structural and Functional Damage to Mitochondria in Myogenic, Oxidatively Stressed C2C12 Cells and Restores Their Differentiation Capacity.The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic DiseasesThree Peptides from Soy Glycinin Modulate Glucose Metabolism in Human Hepatic HepG2 Cells.Adiponectin induced AMP-activated protein kinase impairment mediates insulin resistance in Bama mini-pig fed high-fat and high-sucrose diet.Sirtuins, a promising target in slowing down the ageing process.Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect.5-LO inhibition ameliorates palmitic acid-induced ER stress, oxidative stress and insulin resistance via AMPK activation in murine myotubes.Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes.Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes.Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways.AMP-activated kinase in human spermatozoa: identification, intracellular localization, and key function in the regulation of sperm motility.Abundance in proteins expressed after functional electrical stimulation cycling or arm cycling ergometry training in persons with chronic spinal cord injury.AMPK: guardian of metabolism and mitochondrial homeostasis.A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual.
P2860
Q26747742-C1128BC6-20C1-4FE2-805B-4D610D06D6C1Q28068120-2B373ED9-0E79-455D-B923-CA865BBA26FAQ28081001-EA4AB7BB-1088-46B0-84E3-ECE5EA9783ADQ33808884-CA76EEE5-827C-45A8-9AA9-875118329F80Q33899674-B689B710-D899-4F2B-86B4-21DC7574589DQ34569675-2F51FBB8-677D-472D-BAD4-F4007F03C4EDQ35150698-32688F89-618F-48F6-A1FB-9AF7ED0DDD79Q35296074-D6D7F4CC-3223-4BFB-9217-05DCF81510BDQ35592315-6EA7EC49-6E97-4FC8-A9AD-161E896A09D5Q35624106-89F3D52A-CC6B-4EC4-A684-D010D8FCD863Q35705388-4FC6D032-996D-4BBB-9B20-DAFF25BD894BQ35785215-41011B37-E8B2-4596-AC65-007271863DC3Q35908579-56B5CE1F-084B-475A-A132-99C4C0C600C2Q35935123-33A19A39-BF76-457E-8FB0-B9297565970BQ36550275-897D6530-A18A-473B-8E90-CBD12E40EE05Q36592563-D34D5D0D-33A2-4723-9FE5-E107E4181875Q36626088-281D6E3B-9D05-45E8-81F5-5B19BB0C409DQ36627589-F7E10376-3662-4B3F-B0BE-96DA7C32AE0DQ36847131-7BDA19ED-C027-4485-90BC-64514F51DA55Q36949580-C71C097F-E054-46CD-9935-6F417AD61B7DQ37048904-746B405E-ADA9-46D5-82F7-3D7E587FF7A5Q37111103-3FC0E169-A5C1-4DAD-AF1C-AA75F556CB91Q37126456-DB4E1C83-ACDD-46F7-B119-9A5E9D634F4CQ37472038-5E2D53A8-6C60-4C69-8DCA-2F96ECFBBFC0Q37582435-1FB4AF4C-9C39-45AE-B00A-E0CDBD9722AAQ38393435-3DF5401B-896C-4429-8039-B1416D7B8C10Q38747479-7EB1AE54-5A92-4580-A85C-FB9235175A69Q38763928-89348B41-6C4D-4D06-AE1F-BE3B131CC6E9Q38818701-0660C682-CBC2-4A3E-81DA-BEA31F3EAAFFQ38829914-739D9C57-7BA2-4D7C-A37D-931B4461E74DQ38930264-7F8384B3-EAC5-4D7A-91AB-121AE5E29043Q38978384-4C43491B-AAB3-4EBF-AD6E-F47673D7A092Q40974091-75376EA2-FA00-497A-9465-216BE1649244Q41349411-71509044-41B5-4D87-BCA2-3516EAD418C1Q41445689-62F29E5B-2E35-486A-AD9C-F96F8289E6CCQ42364332-A75E9092-41BE-4CB2-8B23-60CA603D4B9CQ43417919-B6B4D986-2632-4E34-BD05-8AA526A5D7CCQ45044851-DCD213D0-9B5C-4524-8489-04C287B0999BQ45982416-AC7773A8-3AD5-4FCF-A522-F84FF3174BA5Q50000469-D1523692-75C2-430E-B847-6DE5A443C332
P2860
AMPK activation: a therapeutic target for type 2 diabetes?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
AMPK activation: a therapeutic target for type 2 diabetes?
@ast
AMPK activation: a therapeutic target for type 2 diabetes?
@en
type
label
AMPK activation: a therapeutic target for type 2 diabetes?
@ast
AMPK activation: a therapeutic target for type 2 diabetes?
@en
prefLabel
AMPK activation: a therapeutic target for type 2 diabetes?
@ast
AMPK activation: a therapeutic target for type 2 diabetes?
@en
P2093
P2860
P356
P1476
AMPK activation: a therapeutic target for type 2 diabetes?
@en
P2093
Asish K Saha
Kimberly A Coughlan
Neil B Ruderman
Rudy J Valentine
P2860
P304
P356
10.2147/DMSO.S43731
P577
2014-06-24T00:00:00Z